N^2（p—甲基苯磺酰）—L—谷氨酰胺的晶体结构测定

谷氨酰胺衍生物抗瘤酮A_(10)(3-苯乙酰胺基-2,6-哌啶二酮)是从人尿、血液中分离出来的天然广谱性抗肿瘤活性化合物,无明显毒副作用,目前正进行Ⅱ期临床研究.其抗肿瘤的有效成分被认为是它的2个水解产物苯乙酰谷氨酰胶和苯乙酰异谷氨酰胺。De和Pal曾对抗瘤酮A_(10)的类似物如3-对甲苯磺酰胺基-2,6-哌啶二酮等做过抗艾氏腹水癌活性评价,探讨了构效关系.但未见这些化合物的空间结构和电子结构方面的报道.我们合成了抗艾氏腹水癌活性较高的化合物3-对甲苯磷酰胺基-2,6-哌啶二酮的水解产物——对甲苯磺酰谷氨酰胺,并测定了其晶体结构。为进一步研究其分子结构与抗肿瘤活性的关系提供结构数据。     

双黄酮类化合物的合成研究进展

双黄酮类化合物属于黄酮类化合物,具有很多的药理活性如：抗氧化、抗肿瘤、抗炎和抗感染等,许多研究表明双黄酮类化合物的抗氧化、抗炎及抗肿瘤作用优于单黄酮类化合物。由于其独特的分子结构和广泛的药理活性,日益增加的需求使得越来越多的研究者们开始研究其合成方法。本文对双黄酮类化合物的合成方法及其药理活性进行综述,并对各种方法的优缺点进行总结,为进一步研究合成与设计具有药理活性的双黄酮类化合物提供参考,为新药研究与开发提供更加简便高效的方法。     

一系列新型三环二萜的合成与抗肿瘤活性研究

对活性天然产物(+)-7-deoxynimbidiol非对映异构体的外消旋体cis-(±)-7-deoxynimbidiol进行了合成和衍生, 共得到了8个新型三环二萜化合物; 对合成的新化合物进行了抗肿瘤活性的实验研究, 其中化合物5d对人体乳腺癌瘤株MCF7表现出了较强的抑制作用(IC50=7.49 μg/mL), 可能作为新型抗肿瘤药物先导化合物.     

1,5-二(2-羟基苯亚甲基)-二氨基硫脲与银配合物的合成、表征及抗癌活性研究

近年来,由于缩氨基硫脲类过渡金属配合物具有较高的抗癌、抗菌活性,受到化学界和药学界研究人员的广泛重视。实验证明不同缩氨基硫脲与不同过渡金属形成的配合物其抗癌活性不同。1,5－二（2－羟基苯亚甲基）－二氨基硫脲是一种水杨醛缩氨基硫脲类衍生物,而有关其银配合物的合成及抗肿瘤方面的研究目前尚未见报道。鉴于此,我们在以前工作的基础上合成了标题化合物,通过元素分析、红外光谱、紫外光谱、核磁共振氢谱、摩尔电导和溶解性等测试,对配合物进行了表征。同时测定了配体和配合物的抗肿瘤活性,旨在为开发新的抗肿瘤药物提供理论依据。     

3-氨基-4-氯-1H吲唑衍生物的合成及抗肿瘤活性测定

以2,6-二氯苯腈为起始原料通过5步反应合成了9个具有抗肿瘤活性的吲唑类化合物并对其抗肿瘤活性进行了初步筛选.目标产物结构经~1H-NMR和IR确证,体外细胞实验结果显示化合物2c的抗肿瘤活性最好,对K-562、SMMC7721肿瘤细胞有明显抑制作用.     

糖苷合成研究（Ⅳ）──氟脲嘧啶N－葡萄糖醛酸苷的合成及其抗肿瘤活性

合成了１２种新的５－氟脲嘧啶Ｎ－葡萄糖醛酸苷类比合物，其结构用元素分析、ＩＲ、１ＨＮＭＲ等技术确定．初步生物学实验表明，其中有些化合物对小鼠Ｓ－１８０腹水瘤（实体型）具有较高的抑瘤活性．     

糖苷合成研究（Ⅳ）：氟脲嘧啶N—葡萄糖醛酸苷的合成及其…

合成了１２种新的５－氟脲嘧啶Ｎ－葡萄糖醛酸苷类化合物。其结构用元素分析、ＩＲ、＾１ＨＮＭＲ等技术确定。初步生物学实验表明，其中有些化合物对小鼠Ｓ－１８０腹水瘤（实体型）具有较高的抑瘤活性。     

氨基二硫代甲酸酯类抗肿瘤药物研究Ⅰ.哌嗪基二硫代甲酸酯类化合物的合成及活性

发现毒副作用小、活性强的新抗肿瘤药物一直是该领域研究的主要目标.发现结构全新的先导物和新的作用机制是实现这一目标的重要途径.氨基二硫代甲酸酯类化合物具有抗炎、抗菌、杀虫、防腐等生物活性,然而,关于抗肿瘤作用方面的研究却很少有报道.我们在研究中发现了一系列具有明显抗肿瘤作用的氨基二硫代甲酸酯类化合物[1],其中化合物990208经体内抗肿瘤活性和毒性试验证实是最好的化合物之一.为进一步优化化合物990208的结构,研究其构效关系,本文设计合成了一系列990208衍生物.     

(E)-4-取代-1-(喹啉-3-基亚甲基)硫代氨基脲的合成及抗肿瘤活性研究

设计合成(E)-4-取代-1-(喹啉-3-基亚甲基)硫代氨基脲衍生物,并对其体外抗结肠癌性进行研究。以不同硫代异氰酸酯为起始原料,经缩合等反应合成了目标化合物,采用MTT法研究了目标化合物对人结肠癌HCT-116、HCT-8的体外抗肿瘤活性。合成了13个新化合物,其结构经~1H-NMR,~(13)C-NMR和HRMS表征。体外生物活性测试结果显示,大多数化合物具有一定的体外抗肿瘤活性,其中化合物3l活性最优,其对HCT-116、HCT-8细胞的半数抑制浓度(IC_(50))分别为10.10μmol·L~(-1)、9.45μmol·L~(-1)。该系列化合物具有较好的抗肿瘤活性,具有进一步研究的意义。     

氨基酸甲酯取代的尿苷及其衍生物的合成方法及应用

针对目前临床中所面临的耐药性问题，为开发具有抗肿瘤活性的新型结构化合物，以尿苷为原料，首次合成出具有新型结构的氨基酸甲酯取代的尿苷及其衍生物，反应路径合理，后处理简单；对合成的目标化合物进行了初步的抗肿瘤活性实验，结果显示设计合成的甘氨酸甲酯取代的尿苷对肿瘤有一定的抑制作用，为抗肿瘤药物研究奠定重要的基础。     

黄酮类化合物结构修饰及抗肿瘤活性研究进展

我国天然药物和中药资源丰富,种类繁多,可作为先导化合物进行修饰以提高可成药性。其中,黄酮类化合物是自然界中一种常见的天然多酚类化合物,在抗肿瘤方面具有其独特的生物活性;对其进行结构修饰与改造,可提高黄酮类化合物的生物利用度和抗肿瘤活性。本文通过查阅并整理近几年国内外的黄酮类化合物的相关文献,对黄酮类化合物的母核位点进行结构修饰与改造所得的101个黄酮类衍生物及其抗肿瘤活性及作用机制进行综述,同时讨论了构效关系,以期为黄酮类衍生物的结构修饰和抗肿瘤研究提供参考和帮助。     

吲唑酮化合物合成研究进展

吲唑酮作为氮杂环分子当中的重要一员,其分子骨架不仅是有机合成当中的重要中间体,还是许多天然产物和药物分子的核心结构。因此,该类化合物的高效合成一直是合成化学家们的研究热点。本文综述了近二十年来利用过渡金属、高价碘、酸、碱、光、过氧化物以及付-克环化等方法合成吲唑酮骨架的研究进展并展望了吲唑酮化合物合成的研究方向和应用前景     

可见光诱导的1,n-烯炔的自由基串联环化反应研究进展

碳氮杂环化合物广泛存在于天然产物、生物活性分子、药物等相关化合物以及许多其他精细化学品中。近年来,发展了大量的合成方法制备该类化合物。其中,可见光诱导的1,n-烯炔的自由基串联环化反应条件绿色友好、操作简单、化学选择性和官能团兼容性好,已成为制备该类化合物的强有力工具。本文主要根据自由基产生的类型概述了近来可见光诱导的1,n-烯炔的自由基串联环化反应这一快速发展领域的新进展。     

Phenazines and cancer

Phenazines are a large group of natural and synthesised nitrogen-containing heterocycles, including more than 100 different compounds of natural origin and over 6000 synthetic compounds. Many of these compounds have been investigated as potential anti-cancer agents. Despite a large number of research publications, no recent attempt to summarise and critically evaluate the experimental findings relating to the anti-cancer activity of this class of compounds has been made. The present review fills this gap in the literature and discusses both natural and synthetic phenazines with a critical focus on in vitro, in vivo and available clinical anti-cancer activities of these compounds.     

Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa

The leaves of a tropical plant, Mitragyna speciosa KORTH (Rubiaceae), have been traditionally used as a substitute for opium. Phytochemical studies of the constituents of the plant growing in Thailand and Malaysia have led to the isolation of several 9-methoxy-Corynanthe-type monoterpenoid indole alkaloids, including new natural products. The structures of the new compounds were elucidated by spectroscopic and/or synthetic methods. The potent opioid agonistic activities of mitragynine, the major constituent of this plant, and its analogues were found in in vitro and in vivo experiments and the mechanisms underlying the analgesic activity were clarified. The essential structural features of mitragynines, which differ from those of morphine and are responsible for the analgesic activity, were elucidated by pharmacological evaluation of the natural and synthetic derivatives. Among the mitragynine derivatives, 7-hydroxymitragynine, a minor constituent of M. speciosa, was found to exhibit potent antinociceptive activity in mice.     

离子型有机锡化合物的研究进展

介绍了离子型有机锡化合物的分类及其合成方法，并对某些化合物表现出来的 半导体性能、抗肿瘤活性、催化性能以及在合成方法上的应用进行了探讨。     

Natural Products Targeting the Mitochondria in Cancers

There are abundant sources of anticancer drugs in nature that have a broad prospect in anticancer drug discovery. Natural compounds, with biological activities extracted from plants and marine and microbial metabolites, have significant antitumor effects, but their mechanisms are various. In addition to providing energy to cells, mitochondria are involved in processes, such as cell differentiation, cell signaling, and cell apoptosis, and they have the ability to regulate cell growth and cell cycle. Summing up recent data on how natural products regulate mitochondria is valuable for the development of anticancer drugs. This review focuses on natural products that have shown antitumor effects via regulating mitochondria. The search was done in PubMed, Web of Science, and Google Scholar databases, over a 5-year period, between 2015 and 2020, with a keyword search that focused on natural products, natural compounds, phytomedicine, Chinese medicine, antitumor, and mitochondria. Many natural products have been studied to have antitumor effects on different cells and can be further processed into useful drugs to treat cancer. In the process of searching for valuable new drugs, natural products such as terpenoids, flavonoids, saponins, alkaloids, coumarins, and quinones cover the broad space.     

Antioxidant and Antitumor Activities of Newly Synthesized Hesperetin Derivatives

Hesperetin is a class of natural products with a wide range of sources and remarkable biological activities. In this study, we described the synthesis of a series of novel hesperetin derivatives and evaluated the in vitro antioxidant and antitumor activity of these compounds. Eleven novel compounds were synthesized in moderate yields. The compounds synthesized in this work exhibited antioxidant activities against DPPH and ABTS free radicals in a dose-dependent manner. Among them, compound 3f had the best antioxidant activity, with IC₅₀ of 1.2 μM and 24 μM for DPPH and ABTS, respectively. The antitumor activity of the compounds against human cancer cell lines, such as breast MCF-7, liver HepG2, and cervical Hela, was determined by a standard 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay. Three compounds had moderate IC₅₀ values. Interestingly, compound 3f had better biological activity than hesperetin, which matches the prediction by Maestro from Schrödinger. Therefore, the new hesperidin derivative is a promising drug for the treatment of cancer due to its effective antitumor activity. The results also suggested that the antitumor activities of hesperetin derivatives may be related to their antioxidant activities.     

Biological Activity of Newly Synthesized Benzimidazole and Benzothizole 2,5-Disubstituted Furane Derivatives

Newly designed and synthesized cyano, amidino and acrylonitrile 2,5-disubstituted furane derivatives with either benzimidazole/benzothiazole nuclei have been evaluated for antitumor and antimicrobial activity. For potential antitumor activity, the compounds were tested in 2D and 3D cell culture methods on three human lung cancer cell lines, A549, HCC827 and NCI-H358, with MTS cytotoxicity and BrdU proliferation assays in vitro. Compounds 5, 6, 8, 9 and 15 have been proven to be compounds with potential antitumor activity with high potential to stop the proliferation of cells. In general, benzothiazole derivatives were more active in comparison to benzimidazole derivatives. Antimicrobial activity was evaluated with Broth microdilution testing (according to CLSI (Clinical Laboratory Standards Institute) guidelines) on Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus. Additionally, Saccharomyces cerevisiae was included in testing as a eukaryotic model organism. Compounds 5, 6, 8, 9 and 15 showed the most promising antibacterial activity. In general, the compounds showed antitumor activity, higher in 2D assays in comparison with 3D assays, on all three cell lines in both assays. In natural conditions, compounds with such an activity profile (less toxic but still effective against tumor growth) could be promising new antitumor drugs. Some of the tested compounds showed antimicrobial activity. In contrast to ctDNA, the presence of nitro group or chlorine in selected furane-benzothiazole structures did not influence the binding mode with AT-DNA. All compounds dominantly bound inside the minor groove of AT-DNA either in form of monomers or dimer and higher-order aggregates.